Abstract: Clear cell sarcoma (CCS) of tendons and aponeuroses/ malignant melanoma (MM) of soft parts is a rare tumor and in the majority of cases presents a characteristic reciprocal translocation t(12;22)(q13;q12) that results in fusion of the EWS and ATF1 genes. Although the melanocytic differentiation of CCS is indisputable, its precise lineage remains unclear. Typically, the slowly growing tumor affects the extremities of adolescents or young adults, especially around the ankle and foot. CCS is classically regarded as a deep soft tissue tumor associated with tendons or aponeuroses. This traditional view is put into perspective by the description of primary CCS of the gastrointestinal tract that may have a variant fusion gene EWSR1-CREB1. We describe 12 cases of cutaneous CCS and discuss the differential diagnoses. These 12 cases share an identical immunohistochemical profile with MM and thus can easily be confused with a dermal variant of spindle cell MM or metastasis of MM. The patients' ages ranged from 6 to 74 years (median: 25 y), and there was a female predominance (10 females, 2 males). Most tumors (n = 9) were located on the extremities, 2 tumors arose on the back, and 1 on the abdomen. The mean tumor size was 0.97 cm (range, 0.4 to 1.7 cm). Six cases showed invasion of the subcutis, the other 6 cases were entirely dermal. Tumor necrosis was evident in 2 cases, melanin pigment in 2 cases, and ulceration in 1 tumor. All cases showed uniform nests and fascicles of pale spindled or slightly epitheloid cells with finely granular eosinophilic or clear cytoplasm. There was fair pleomorphism with plump spindled nuclei and significantly prominent nucleoli. Multinucleated wreath-like tumor giant cells were observed in two-thirds of cases, but were usually present only focally. The dense cellular aggregates were encased by delicate fibrous septa. The stroma showed a sclerotic reticulated pattern. Partly, the nests of spindle cells bordered the epidermis, prima vista mimicking junctional nests of melanocytes. The specific translocation pattern was confirmed in all cases by fluorescence in situ hybridization. Local recurrences and metastases developed in 2 and 3 patients, respectively, and 1 patient died of the disease. The tumor has a proclivity to involve the tendons and aponeuroses of distal extremities of adolescents or young adults, with a peak incidence in the third and fourth decade and a slight female predominance. The tumor is usually deep seated and characterized by multiple local recurrences with late metastases and a high rate of tumor deaths. Pathologic findings include fascicles and nests of pale fusiform and epitheloid tumor cells with clear or finely granular, eosinophilic cytoplasm and elongated oval nuclei with prominent nucleoli, and scattered mitoses. The cellular aggregates are encased by delicate fibrous septa and in two-thirds of cases multinucleated giant cells are observed. CCS shows consistent evidence of melanocytic differentiation. By electron microscopy, melanosomes in varying stages of development can be identified in the majority of the cases. 3, 13, 15, 19 Immunohistochemically, distinction from MM is not possible because both tumors share positivity for the melanocytic markers S-100, HMB-45, MelanA, and microphthalmia transcription factor. As the histologic and immunohistochemical features of CCS overlap with those of cutaneous spindle cell melanoma and occult metastatic melanoma, the differential diagnosis between these entities is still problematic with profound clinical consequences. 8, 26 Characteristically, cytogenetic analysis of CCS indicates in most cases the presence of a reciprocal translocation, t(12;22)(q13;q12) that has not yet been identified in malignant melanoma. 23 The gene fusion product involves the EWS (22q12) and ATF1 (12q13) genes. This translocation has been detected cytogenetically in about 75% of reported cases of CCS. In addition, another fusion of EWS to CREB1, a gene at 2q13, has been found
C lear cell sarcoma (CCS) of tendons and aponeuroses/ malignant melanoma (MM) of soft parts is a unique sarcoma initially described by Franz Enzinger in 1965. 10 The tumor has a proclivity to involve the tendons and aponeuroses of distal extremities of adolescents or young adults, with a peak incidence in the third and fourth decade and a slight female predominance. The tumor is usually deep seated and characterized by multiple local recurrences with late metastases and a high rate of tumor deaths. Pathologic findings include fascicles and nests of pale fusiform and epitheloid tumor cells with clear or finely granular, eosinophilic cytoplasm and elongated oval nuclei with prominent nucleoli, and scattered mitoses. The cellular aggregates are encased by delicate fibrous septa and in two-thirds of cases multinucleated giant cells are observed. CCS shows consistent evidence of melanocytic differentiation. By electron microscopy, melanosomes in varying stages of development can be identified in the majority of the cases. 3, 13, 15, 19 Immunohistochemically, distinction from MM is not possible because both tumors share positivity for the melanocytic markers S-100, HMB-45, MelanA, and microphthalmia transcription factor. As the histologic and immunohistochemical features of CCS overlap with those of cutaneous spindle cell melanoma and occult metastatic melanoma, the differential diagnosis between these entities is still problematic with profound clinical consequences. 8, 26 Characteristically, cytogenetic analysis of CCS indicates in most cases the presence of a reciprocal translocation, t(12;22)(q13;q12) that has not yet been identified in malignant melanoma. 23 The gene fusion product involves the EWS (22q12) and ATF1 (12q13) genes. This translocation has been detected cytogenetically in about 75% of reported cases of CCS. In addition, another fusion of EWS to CREB1, a gene at 2q13, has been found in a subset of CCS that arouse preferentially in the gastrointestinal tract. 1 Besides, both molecular genetic changes have been reported in cases of angiomatoid fibrous histiocytoma. 2, 12 Adverse prognostic factors identified to date, include larger tumor size as a continuous variable and any microscopic tumor necrosis. 9, 20, 22 No correlation was found between clinical course, histologic, and immunohistochemical features, including proliferative activity. 19, 21 CCS frequently develops recurrences and metastases 5 years and more subsequent to initial therapy, indicating the need for long-term follow-up and treatment. 6, 10 Surgery is the mainstay of treatment, with chemotherapy having little effect. 17 Early diagnosis and initial wide excision are essential for a favorable outcome of CCS.
14 As of the rarity of CCS, furthermore characterization of the tumor is necessary to strengthen the understanding of this particular sarcoma and to facilitate making accurate diagnosis. In this study, we included only cutaneous cases of CCS with typical morphologic findings and proven EWSR1 rearrangement by fluorescence in situ hybridization technique.
MATERIALS AND METHODS
For this study, all cases were collected from the routine diagnostic files and consultation cases of the authors. The patients, 10 female and 2 male, were 6 to 74 years old (median: 25 y). Detailed clinical features are summarized in Table 1 . Tumors were assessed as entirely dermal when there was neither infiltration of the subcutis in step sections, nor evidence of any tumor rest by reexcision. Each patient was staged meticulously by its clinicians to rule out the facts that primary tumors were not metastases to the skin by prior deep soft tissue CCS and metastases from the detected primary cutaneous CCS.
All specimens were fixed in 4% buffered formalin, routinely processed, and embedded in paraffin; 4 mm thick sections were stained routinely with hematoxylin and eosin. In addition, sections in all cases were stained immunohistochemically by the labeled Streptavidin Biotin technique using Anti-Human Melanosome (Clone HMB-45, 1:300, DAKO, Glostrup, Denmark, no pretreatment), anti-S-100 protein (polyclonal, 1:2000, DAKO, Glostrup, Denmark, no pretreatment), anti-Human Melan-A (Clone A103, 1:50, DAKO, Glostrup, Denmark, pretreatment with standard antigen retrieval), and anti-Melanoma associated antigen (Clone NKI/C3, 1:200, BioGenex, SanRamon, USA, no pretreatment). Local ethical guidelines were followed for this study.
FISH Analysis
To detect the translocation of the EWSR1 gene on 22q11 a directly FITC/Rhodamine-labeled break apart probe was used (Abbott, Bergisch Gladbach, Germany). Fluorescence in situ hybridization was carried out on 3 mM sections of formalin-fixed, paraffin-embedded tissue after heating at 651C for 16 hours, deparaffinization with xylene, and dehydration with ethanol. All tissue sections were pretreated with a 30% solution of Oncor pretreatment powder in 2 Â SSC and digested for 10 minutes with Proteinase K following the instructions of the suppliers (Q-Biogene, Heidelberg, Germany). After a second dehydration step, the probes were applied to the sections and the covered slides were sealed with rubber cement, heat-denatured, and hybridized at 371C for 16 hours. All sections were counterstained with DAPI II in mounting medium (125 ng/mL, Vysis Bergisch Gladbach, Germany) and visualized under a Zeiss Axioplan microscope using a HBO100 lamp and the appropriate filters for the 3 fluorescent dyes. All EWS FISH analyses were carried out in the same lab. At least 50 nuclei were counted with the exception of 2 cases (Table 1) . Identification and enumeration of nuclei was carried out by a dermatopathologists and a molecular biologist simultaneously. The number of counted nuclei varies because only intact nuclei of tumor cells showing the 4 signals (2 orange and 2 green signals) were counted. In addition, only those nuclei were evaluated in which the whole membrane was visible, to avoid incorrect results derived from nuclei lying closely together that cause difficulties in distinguishing the nuclei and identifying the appropriate signals. All EWS FISH analyses were carried out with 1 positive and 2 negative controls. For the positive control Ewing sarcomas with a proven EWS translocation were used, the negative controls included melanomas and synovial sarcomas.
RESULTS
The clinical features of patients with cutaneous CCS are summarized in Table 1 . There was a female predominance with 10 female patients and 2 male patients with ages ranging from 6 to 74 years (median: 25 y). Most tumors (9) were located on the extremities, and 2 tumors arose on the back, 1 on the abdomen. The mean tumor size was 0.97 cm (range, 0.4 to 1.7 cm) measured under the microscope. A sentinel lymph node operation was carried out in 2 cases (Cases 1 and 10). There was a metastasis to a sentinel lymph node in Case 10 in the left axilla Histologically, 6 neoplasms were confined to the dermis (Figs. 1-3 ). An infiltration of superficial parts of the subcutis was noted in the remaining 6 cases. The salient histologic features of all tumors were dense nests and fascicles divided by fine fibrous tissue septa and a pronounced hyalinized stroma (Fig 4) . In 6 cases, the nests bordered the epidermis mimicking junctional nests of a melanocytic tumor. None of these cases showed an increase of single melanocytes in the basal epidermal layer or transepidermal spread of atypical melanocytes. One case presented ulceration, necrosis was observed in 2 cases, and melanin pigment in 2 other tumors. The pale fusiform and epitheloid cells showed clear or finely granular, eosinophilic cytoplasm. There was fair pleomorphism with plump spindled nuclei and prominent nucleoli. The mitotic activity ranged from 2 to 20 mitotic figures (MF)/ 10 high-power fields (HPF) (mean: 8MF/10 HPF). In the current immunohistochemical assessment, the tumors expressed the individually carried out melanocytic markers, except negativity for MelanA in Cases 2 and 9. EWSR1 rearrangement was proven in all cases by fluorescence in situ hybridization technique (Fig 5) . Case 10, recently illustrated in a different study and successfully tested by RT-PCR, 31 harbored an EWSR1-CREB1 chimeric transcript. Detailed histologic and immunohistochemical findings are summarized in Table 2 . 
DISCUSSION
The cytogenetic hallmark of CCS is t(12;22) (q13;q12), resulting in a chimeric EWSR1/ATF1 gene in which the 3 0 -terminal part of EWS at 22q is replaced by the 3 0 -terminal part of ATF1 at 12q. 4, 8, 16, 27, 29, 30 CCS can also display additional chromosomal aberrations including extra copies of chromosomes 2, 7, and 8 and additional abnormalities of chromosome 22. 4, 5 The EWSR1/ATF1 fusion transcript can be identified by reverse transcription-polymerase chain reaction and fluorescence in situ hybridization techniques. 15 Four types of EWSR1/ATF1 chimeric transcripts have been identified in CCS, designated type 1 to 4. 24 No significant association between the transcript type and outcome of the patient was found. 7 A subset of CCS that occurs preferentially in the gastrointestinal tract may have a variant fusion gene EWSR1-CREB1 and can show little or no melanocytic differentiation.
1 This is in contradiction with an earlier study of partly the same authors in which gene expression profiles were supposed to support the classification of CCS as a distinct genomic subtype of melanoma characterized by its deep soft tissue primary location, lack of cutaneous invasion, and is distinguished from a primary cutaneous melanoma primarily by its anatomic location and clinical features. 28 In addition, EWSR1-CREB1 was of our study providing further evidence that this chimeric variant is not exclusive to gastrointestinal CCS. 31 In contrast to melanoma, mutations of exon 11 and 15 of the BRAF gene are consistently negative in clear cell sarcoma, suggesting different genetic pathways for these tumors. 25 Microsatellite instability, a variation in the length of short repeat DNA segments in the genome, has been implicated in melanoma tumorigenesis, but is rare or absent in CCS. 11 As the histologic and immunohistochemical features overlap, cutaneous CCS can be confused with cutaneous spindle cell melanoma or metastasis of melanoma. Immunohistochemically, distinction from MM is not possible as both tumors share positivity for the common melanocytic markers such as S-100, HMB-45, MelanA, and NKI/C3. Histologically, some tumors even present melanin pigment such as 2 cases in our series and the dense fascicles of spindle cells closely bordering the epidermis and invading the papillary dermis mimic junctional nests of melanocytes. Still, there are reliable criteria for the accurate histologic diagnosis of cutaneous CCS before involving molecular techniques for evidence. Cutaneous CCS shows a uniform pattern of fascicles of spindle cells throughout the entire tumor. The fascicles are encased by delicate fibrous septa and mostly show a characteristic hyalinized sclerotic and reticulated stroma, a pattern that is unlikely to be found in melanoma and should lead to the working diagnosis of cutaneous CCS. Melanoma and its metastases often show more than 1 population of cells within 1 lesion. None of the tumors in our study, even those mimicking junctional melanocytic nests, show a pagetoid spread with atypical melanocytes scattered in neither the epidermis nor any significant increase of melanocytes within the basal epidermis layer. Multinucleated giant cells are usually not a feature of melanoma, but can occur sporadically. We found multinucleated giant cells in two-thirds of our cases, albeit In his original work Enzinger concluded that the cell of origin of CCS was unclear stating that ''ythe term CCS of tendons and aponeuroses yis purely descriptive and reflects the uncertainty of histogenesis.'' He furthermore stated that it was not related to fibrosarcoma or synovial sarcoma, and that it was not a spindle cell melanoma. In a subsequent paper coauthored with Chung in 1983, 6 he reassessed his point of view and they stated that ''y the presence of melanin was overlooked y,'' and thus concluded that a more appropriate term would be ''y MM of soft parts, rather than the purely descriptive term of clear cell sarcoma.'' Later, other authors stated that CCS was a preferable term, because CCS was clinically very unlikely to be cutaneous melanoma. 17 This original dilemma has continued to date and CCS is still viewed as a tumor of uncertain differentiation despite the detection of intracellular melanin and melanosomes. Furthermore characterization of this neoplasm is required to strengthen the understanding of this particular sarcoma. Long-term follow-up studies are necessary to analyze if there are statistical differences in the prognosis of cutaneous CCS and comparable melanoma. This series expands the spectrum of CCS to include lesions that are based in the dermis and should be distinguished from cutaneous melanoma.
In summary, the histologic criteria stated above can lead to the rare diagnosis of cutaneous CCS. It has to be distinguished from melanoma. In questionable cases, definitive diagnosis is possible with molecular confirmation of the sarcoma defining translocation.
